SCHEMBL13972318

SCHEMBL13972318

C=C(C)c1cc(NC(=O)CNc2ccc(Oc3ccncc3)cc2)no1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 9/20 0.48
RIPK2 O43353 1/20 0.48
GRK2 P25098 4/20 0.40
GRK3 P35626 2/20 0.40
ROCK2 O75116 1/20 0.40
GALR3 O60755 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPK13 O15264 1/20 0.38
MAPK12 P53778 1/20 0.38
MAPK11 Q15759 1/20 0.38
MAPK14 Q16539 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
NLRP1 Q9C000 1/20 0.37
MMP1 P03956 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13823425 0.90 GRK2 (0.53) RAF1RIPK2GRK2GRK3ROCK2
SCHEMBL13823410 0.83 RAF1 (0.50) RAF1RIPK2GRK2GRK3ROCK2
SCHEMBL14136181 0.83 RAF1 (0.50) RAF1RIPK2GRK2GRK3ROCK2
SCHEMBL4444438 0.82 RAF1 (0.72) RAF1RIPK2MAPK13MAPK12MAPK11
SCHEMBL4441367 0.74 RAF1 (0.73) RAF1RIPK2GRK2GALR3MAPK13
SCHEMBL4443071 0.72 RAF1 (0.61) RAF1RIPK2GRK2GRK3MAPK13
SCHEMBL13815845 0.72 RAF1 (0.72) RAF1RIPK2MAPK13MAPK12MAPK11
SCHEMBL9892908 0.71 EGFR (0.44) KDM4EALDH1A1MAPTKMT2A
SCHEMBL13823442 0.70 ALDH1A1 (0.62) HSD17B10KDM4EALDH1A1MAPTKMT2A
SCHEMBL14402939 0.69 RAF1 (0.49) RAF1RIPK2HSD17B10MAPK14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476683-B2 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty MERCK PATENT GMBH (DE) 2009-01-13 US disclosed